A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2011
11/09/2011	CN102232953A Medicinal composition containing Esopiclone and preparation method thereof
11/09/2011	CN102232939A Novel mecobalamin sustained-release capsule and preparation method thereof
11/09/2011	CN102232935A Novel oral mecobalamin sustained-release tablets and preparation method thereof
11/09/2011	CN102232924A Asarin pulmonary delivery system
11/09/2011	CN102232615A Health-care Chinese herbal medicine cigarettes
11/09/2011	CN102232553A Nutrient absorbing composition
11/09/2011	CN101966151B Trimipramine maleate liposome solid preparation
11/09/2011	CN101940710B Health-care wine for regulating sleep and preparation method thereof
11/09/2011	CN101926835B Method for extracting gingko total terpene lactones and injection containing same
11/09/2011	CN101890135B Antidepressant traditional Chinese medicine composition and application thereof
11/09/2011	CN101884638B Application of 5alpha-androstane-3beta,5,6beta-triol in preparing neuro-protective medicaments
11/09/2011	CN101850087B Medicinal composition used for alleviating pains and preparation method and application thereof
11/09/2011	CN101837000B Application of 2-fluroin-beta-D-glycoside in treating neuropathic pain
11/09/2011	CN101804096B Method for extracting purified total alkaloid of strychnos nux-vomica and application thereof in pharmacy
11/09/2011	CN101797292B Chinese medical pillow core for curing insomnia and preparation method thereof
11/09/2011	CN101757571B Externally-applied traditional Chinese medicine composition for treating brain tumor and preparation method thereof
11/09/2011	CN101747280B Method for preparing detomidine and the intermediate thereof
11/09/2011	CN101698094B Distillate for treating white vein diseases and preparation method thereof
11/09/2011	CN101642465B Application of Kadsura heteroclite (Roxb.) Craib polysaccharide of Guangdong province for preparing medicaments for preventing and/or treating senile dementia
11/09/2011	CN101591375B Compound with analgesic activity, preparation method and application thereof
11/09/2011	CN101559156B Application of traditional Chinese medicine composition in preparing medicament for curing chronic inflammatory demyelinating polyneuropathy
11/09/2011	CN101420982B Dry direct compression fast disintegrating tablet
11/09/2011	CN101406680B Compound syrup paste for epilepsy
11/09/2011	CN101280016B Cocaine-and amphetamine-regulated transcript peptides single-chain antibody and application thereof
11/09/2011	CN101273040B Oxadiazolyl pyrazolo-pyrimidines as MGLUR2 antagonists
11/09/2011	CN101204433B Chinese patent medicine decoction for migraine
11/09/2011	CN101161245B Purpose of toluylene glycosides and its derivant for restraining synapse ribonucleoprtein excess expression
11/08/2011	US8053599 Drug containing (2R)-2-propyloctanoic acid as the active ingredient
11/08/2011	US8053576 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety, muscle relaxants, anxiolytic agents; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene
11/08/2011	US8053476 Method for treating peripheral neuropathic pain
11/08/2011	US8053436 9-(piperazinylalkyl) carbazoles as bax-modulators
11/08/2011	US8053432 Cyclic hydroxylamine as psychoactive compounds
11/08/2011	US8053431 Pharmaceutical use of substituted amides
11/08/2011	US8053413 Ameliorating breathing disorder using cholecystokinin (CCK) receptor antagonist
11/08/2011	US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011	US8053407 Methods of treating neurological conditions with hematopoeitic growth factors
11/08/2011	US8052980 Use of the neurotoxic component of a botulinum toxin for treating arthritis
11/08/2011	CA2643300C Trans-fused chromenoisoquinolines, synthesis and methods for use
11/08/2011	CA2601132C Use of n-methylglycine and pharmaceutical compositions comprising n-methylglycine for treating neuropsychiatric disorders
11/08/2011	CA2529126C Azetidine compounds
11/08/2011	CA2516263C Benzofuranoxyethylamines as antidepressants and anxiolytics
11/08/2011	CA2509982C N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
11/08/2011	CA2509072C Saturated and unsaturated heteroarylcycloalkylmethyl-amines as antidepressants
11/08/2011	CA2498945C Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles from cyclohexanes and cyclohexanones as intermediates
11/08/2011	CA2493436C Indolinone derivatives, substituted in the 6-position, their preparation and their use as medicaments
11/08/2011	CA2459230C Peptidic compounds selectively binding to p-selectin
11/08/2011	CA2443105C Functional role for cannabinoids in autonomic stability during sleep
11/08/2011	CA2442182C Modulation of pd-1 interactions with its ligands
11/08/2011	CA2432185C Substituted pyridoindoles as serotonin agonists and antagonists
11/08/2011	CA2431675C Novel sulfamides and their use as endothelin receptor antagonists
11/08/2011	CA2415399C Use of strains of the parapox ovis virus against organ fibrosis
11/08/2011	CA2302754C Noribogaine in the treatment of pain and drug addiction
11/08/2011	CA2249596C Methods for enhancing functional recovery following central nervous system ischemia or trauma
11/04/2011	CA2758029A1 Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
11/03/2011	WO2011137331A2 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators
11/03/2011	WO2011137319A2 Stabilized fibronectin domain compositions, methods and uses
11/03/2011	WO2011137313A1 Aza-bicyclic amine n-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs
11/03/2011	WO2011136744A1 Eif4e binding peptides
11/03/2011	WO2011136723A1 Polymorphs of a metabotropic glutamate receptor positive allosteric modulator
11/03/2011	WO2011136378A1 Grafting material for genetic and cell therapy
11/03/2011	WO2011136376A1 Enteric tablet
11/03/2011	WO2011136373A1 Enteric tablet
11/03/2011	WO2011136318A1 Therapeutic agent and preventative agent for alzheimer's disease
11/03/2011	WO2011136308A1 Prophylactic or therapeutic agent for diseases associated with pains in urinary organs
11/03/2011	WO2011136292A1 Novel amide derivative and use thereof as medicine
11/03/2011	WO2011136288A1 Transdermally absorbable donepezil-containing preparation
11/03/2011	WO2011136247A1 Novel heteroaryl monocyclic pyrimidine derivative
11/03/2011	WO2011136233A1 Self-renewal promoter for neural stem cells and method for using same
11/03/2011	WO2011136192A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE
11/03/2011	WO2011135332A2 Nmn modulator
11/03/2011	WO2011135276A1 3, 3 -disubstituted- ( 8 - aza - bicyclo [3.2.1] oct- 8 - yl) -[5- (1h - pyrazol - 4 -yl) -thiophen-3 -yl] methanones as inhibitors of 11 (beta) -hsd1
11/03/2011	WO2011135007A1 New compounds, synthesis and use thereof in the treatment of pain
11/03/2011	WO2011134877A1 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
11/03/2011	WO2011134098A1 Method for inhibiting tau protein aggregation and treatment of alzheimer's disease with a compound derived from quinoline
11/03/2011	WO2011134075A1 Sox9 inhibitors
11/03/2011	WO2011134019A1 Novel biphenyl sartans
11/03/2011	WO2011107653A3 Use of levodopa, carbidopa and entacapone for treating parkinson's disease
11/03/2011	WO2011104414A3 Compounds for treating alzheimer's disease
11/03/2011	WO2011104411A3 Compounds for treating alzheimer's disease
11/03/2011	WO2011089576A3 Novel compositions for reducing abeta 42 production and their use in treating alzheimer's disease (ad)
11/03/2011	WO2011075699A3 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/03/2011	WO2011066378A3 Antagonists of il-6 to prevent or treat thrombosis
11/03/2011	WO2011066285A3 Peptide-based treatment for neurodegenerative diseases
11/03/2011	WO2011065767A3 Composition for promoting the activity of peroxisome proliferator-activated receptor-δ
11/03/2011	WO2011063415A9 Methods for treating mild cognitive impairment
11/03/2011	WO2011056037A3 Pharmaceutical composition containing, as active ingredients, lindera erythrocarpa extracts, fractions thereof, or compounds separated from the extracts
11/03/2011	WO2011056033A3 Pharmaceutical composition for preventing / treating trpv1 activity-related and inflammation-related diseases or conditions containing maillard peptide separated from well-aged traditional soy sauce as active ingredient
11/03/2011	WO2011055944A3 Methods for treating fibromyalgia syndrome
11/03/2011	WO2011052968A3 Composition for preventing or treating degenerative neurological disorder, containing oleanonic acid
11/03/2011	WO2011049346A3 Compositions for improving migration potential of stem cells
11/03/2011	WO2011047183A3 Use of a neuregulin to treat peripheral nerve injury
11/03/2011	WO2011044082A3 Compositions and methods for inhibiting madcam
11/03/2011	US20110271358 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
11/03/2011	US20110270156 High shear application in medical therapy
11/03/2011	US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011	US20110269970 Phenethanolamine Derivatives for Treatment of Respiratory Diseases
11/03/2011	US20110269842 Compositions comprising cb receptor agonists, uses thereof and methods for their preparation
11/03/2011	US20110269833 Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
11/03/2011	US20110269826 Method
11/03/2011	US20110269820 Spinal muscular atrophy treatment via targeting smn2 catalytic core

1 ... 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 ... 1833